ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

IMRIS Receives CE Mark for Integrating Latest Generation MR Scanners within VISIUS Surgical Theatre in European Market

Print | 
Email |  Comment   Share  

IMRIS
5101 Shady Oak Rd
Minnetonka, MN, 55343
USA



Acrobat PDF  Additional information provided by manufacturer

Press release date: July 23, 2014

MINNEAPOLIS - Core MRI technology provides most advanced scanners for highest intraoperative image quality and best workflow available

IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the Company has obtained regulatory CE mark for integrating the next generation MRI core technology into the VISIUSŪ Surgical Theatre, allowing for sales and marketing in the European Union.

This newest imaging technology, based on the Siemens Aera 1.5T(tesla) and Skyra 3.0T MRI scanners, helps IMRIS deliver even better image quality, faster 3D image acquisition, and improved ease-of-use and workflow during surgical procedures using intraoperative MRI (iMRI). The Company received United States Food and Drug Administration (FDA) approval for these advancements in February 2014.

"These high-field intraoperative scanner options will give a hospital's clinical team state-of-the-art applications and image quality that increase productivity," said IMRIS President and CEO Jay D. Miller. "We bring the latest and unequaled imaging technology into the operating room where it can make the most difference - during the surgery. More and more neurosurgical centers are using image guidance with VISIUS iMRI for an expanding list of conditions and procedures and adjunctive interventions beyond brain tumor resections, such as laser ablation for tumors and epilepsy using stereotactic tools, deep brain stimulation (DBS) and other minimally-invasive techniques that are designed to improve patient outcomes."

Inside a VISIUS Surgical Theatre equipped with high-field iMRI, surgeons have on-demand access to real-time data and state-of-the-art imaging during the procedure as the scanner uniquely moves on ceiling-mounted rails. The Company also designs and manufactures proprietary intraoperative CTs, head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 58 leading medical institutions around the world.

For further information:
Kevin J. Berger
Marketing Communications Manager
IMRIS, Inc.
Tel: +1-763-203-6332
Email: kberger@imris.com

IMRIS Inc.

Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Vision Systems
| Featured Manufacturing Jobs
 Other News from this company:
SYMBIS Surgical System Named to 2014 Space Technology Hall of Fame
IMRIS Obtains CE Mark for First Ceiling-Mounted Intraoperative CT Solution
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Medical Imaging Systems


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address